search
Back to results

Paravertebral Block for Inguinal Hernia Repair in Elderly

Primary Purpose

Inguinal Hernia Repair

Status
Completed
Phase
Not Applicable
Locations
Lebanon
Study Type
Interventional
Intervention
Paravertebral block injections from T12 to L2
Placebo at T11 and L3
Paravertebral block injections between T11 and L3
Herniorrhaphy
Intravenous (IV) fentanyl
Bupivacaine
Sponsored by
Makassed General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inguinal Hernia Repair

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients admitted to undergo elective unilateral inguinal hernia repair
  • patients with ASA II, III or IV

Exclusion Criteria:

  • bilateral inguinal hernia
  • incarcerated hernia
  • emergency cases
  • known history of allergic reactions to local anesthesia
  • bleeding disorders
  • neurological disorders
  • infection at site of injection

Sites / Locations

  • Makassed General Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Three PVB injections

Five PVB injections

Arm Description

Patients will receive three PVB injections from T12 to L2 and placebo at T11 and L3

Patients will receive five PVB injections between T11 and L3.

Outcomes

Primary Outcome Measures

Mean arterial pressure (MAP) for hemodynamic stability

Secondary Outcome Measures

Pain assessed through the Verbal Numeric Rating Scale (VNRS).

Full Information

First Posted
August 25, 2015
Last Updated
January 2, 2018
Sponsor
Makassed General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02537860
Brief Title
Paravertebral Block for Inguinal Hernia Repair in Elderly
Official Title
Paravertebral Block for Inguinal Hernia Repair in Elderly: Randomized Double-blinded Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
December 2015 (undefined)
Primary Completion Date
December 30, 2017 (Actual)
Study Completion Date
December 30, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Makassed General Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This prospective double-blinded clinical trial is intended to compare three nerve stimulator- guided paravertebral block injections versus five injections for elderly patients undergoing hernia repair regarding intraoperative hemodynamic stability and postoperative pain.
Detailed Description
Introduction The most effective anesthetic technique for inguinal hernia repair remains a controversial issue; however, paravertebral block (PVB) has resulted in significant postoperative analgesia, less postoperative nausea and vomiting (PONV) and short hospital stay compared to general anesthesia (GA), spinal anesthesia (SA) and ilioinguinal nerve block. Elderly patients usually have higher risk for developing mental disturbances and cardiopulmonary complications following GA. Hence, elderly patients may benefit from PVB. Although PVB has shown satisfactory outcome; nevertheless, there is no standardized PVB regarding the technique and number of injections. Based on this background, the objective of this prospective double-blinded study is to compare three nerve stimulator- guided PVB injections versus five injections for elderly patients undergoing hernia repair regarding intraoperative hemodynamic stability and postoperative pain. Methods Following approval of the Institutional Review Board, written informed consent will be obtained from 200 patients aged above 65 years with ASA II, III or IV admitted to undergo elective unilateral inguinal hernia repair between September 2015 and September 2016. The sealed envelope technique is used to divide the patients into two groups. Group III (100 patients) will receive three PVB injections from T12 to L2 and placebo at T11 and L3. Group V (100 patients) will receive five PVB injections between T11 and L3. The anesthetist, surgeon, patient and data collector are all blind to the patients' group. ECG leads, pulse oximetry and non-invasive oscillometric arterial pressure are attached. Patients will be given 1 µg/kg intravenous (IV) fentanyl (Fentanyl Hameln 10 ml, 0.05 mg/ml, Hameln Pharmaceuticals, Germany) as premedication. Unilateral PVB will be performed while the patient is in the lateral decubitus position with the side to be operated being upwards. Sites of injection are marked 2.5-3 cm lateral to the midline of the vertebral column. Paravertebral block technique Following aseptic preparation of the skin, the injection sites are infiltrated with 0.1 ml of lidocaine 1% each using an 8 mm, 30 G needle (BD Micro-Fine Plus, Becton Dickinson and company, USA). PVB injections are done using a 100 mm 22 G nerve stimulator needle (Stimuplex, B.Braun, Melsungen, Germany). The injections begin at L3 and proceed upwards reaching to T11. The needle is introduced perpendicularly to the skin at the site of the injection point using the following nerve stimulator settings: 5mA, 9V and 2Hz. The stimulating needle is gently manipulated into a position to allow for an adequate muscular response with a stimulating current of 0.4-0.8 mA. Then, the injection is performed. Block onset is determined by cold test and pinprick test. In order to preserve the double blindness of this clinical trial, two syringes will be used for both groups. The first syringe labeled (A) (20 ml) is filled with 15 mL of solution and used to perform equal injections at the levels T12, L1, and L2 (5mL each). The second syringe labeled (B) (10 ml) is used to inject the solution at the levels T11 and L3 (5 ml each). To ensure equal anesthetic dose of 75 mg of bupivacaine for each patient, the syringes are prepared as follows: For group V, both syringes (A) and (B) contain 3mg of bupivacaine/ml whereas for group III, the syringe (A) is prepared with 5 mg bupivacaine/ml while syringe (B) contains placebo. To allow for adequate blinding, the solution used for injection (saline or local anesthetic mixture) is prepared by an independent nurse outside the operating room. If a patient feels pain during the surgery, 50 - 100 µg IV fentanyl will be given and followed by 0.4-0.5 mg/kg propofol if needed while keeping the patient responsive to verbal stimulation. If the latter is not sufficient, the patient is converted to GA. Data Collection Demographic and preoperative variables are collected. Time to perform the block, intraoperative hemodynamic monitoring (MAP and HR) are noted during the entire surgery and recorded pre-incision, at skin incision, at inguinal hernia sac traction, and upon wound closure. Supplemental intraoperative fentanyl and propofol is recorded. Surgery duration, incidence of PONV and numbness are noted. Patients' satisfaction is also assessed based on their comfort and activity during the procedure, intra- and postoperatively. Patient's comfort is determined by: feeling of pain, PONV, and negative memory of the procedural experience. The patient's activity is based on the ability to sit, move and walk. Patients rate these on a scale of one to three ranging from satisfied, partially satisfied, and unsatisfied. Surgeon's satisfaction is based on the overall intra- and postoperative status of the patient. It is measured based on the following: patient's movement or feeling pain during the operation, self-transportation from the surgical table to stretcher, and postoperative pain. Postoperative pain is assessed during the first five postoperative days (0 hr, 6 hr, 12 hr, and day 1 till day 5) using the Verbal Numeric Rating Scale (VNRS) (0 no pain and 10 worst possible pain). Patients will be discharged the same day once they had urinated and demonstrated ability to tolerate oral diet. Data will be collected during the hospital stay by residents blind to the patient's group. Patients will be contacted by the same resident during the follow-up period through daily phone calls.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inguinal Hernia Repair

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Three PVB injections
Arm Type
Experimental
Arm Description
Patients will receive three PVB injections from T12 to L2 and placebo at T11 and L3
Arm Title
Five PVB injections
Arm Type
Experimental
Arm Description
Patients will receive five PVB injections between T11 and L3.
Intervention Type
Other
Intervention Name(s)
Paravertebral block injections from T12 to L2
Intervention Description
Three anesthetic injections are done
Intervention Type
Other
Intervention Name(s)
Placebo at T11 and L3
Intervention Description
Two injections that contain saline are performed
Intervention Type
Other
Intervention Name(s)
Paravertebral block injections between T11 and L3
Intervention Description
Five anesthetic injections are done
Intervention Type
Procedure
Intervention Name(s)
Herniorrhaphy
Intervention Description
Unilateral inguinal hernia repair
Intervention Type
Drug
Intervention Name(s)
Intravenous (IV) fentanyl
Intervention Description
Patients will be given 1 μg/kg intravenous (IV) fentanyl as premedication
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Intervention Description
Each patient will receive 75 mg bupivacaine during PVB
Primary Outcome Measure Information:
Title
Mean arterial pressure (MAP) for hemodynamic stability
Time Frame
Patients will be monitored during the operation, an expected average of 90 minutes
Secondary Outcome Measure Information:
Title
Pain assessed through the Verbal Numeric Rating Scale (VNRS).
Time Frame
5 postoperative days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients admitted to undergo elective unilateral inguinal hernia repair patients with ASA II, III or IV Exclusion Criteria: bilateral inguinal hernia incarcerated hernia emergency cases known history of allergic reactions to local anesthesia bleeding disorders neurological disorders infection at site of injection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zoher Naja
Organizational Affiliation
Chairperson of Anesthesia department
Official's Role
Principal Investigator
Facility Information:
Facility Name
Makassed General Hospital
City
Beirut
Country
Lebanon

12. IPD Sharing Statement

Citations:
PubMed Identifier
30446826
Citation
Naja Z, Kanawati S, Khatib ZE, Ziade F, Nasreddine R, Naja AS. Three versus five lumbar paravertebral injections for inguinal hernia repair in the elderly: a randomized double-blind clinical trial. J Anesth. 2019 Feb;33(1):50-57. doi: 10.1007/s00540-018-2582-9. Epub 2018 Nov 16.
Results Reference
derived

Learn more about this trial

Paravertebral Block for Inguinal Hernia Repair in Elderly

We'll reach out to this number within 24 hrs